A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.
LONDON, April 6 (Reuters) - Cuts to aid budgets are threatening to undermine years of progress in reducing the number of women dying during pregnancy and childbirth, and could lead to a rise in deaths, the United Nations has warned.
